- Home
- EXEL vs ALV Comparison
EXEL vs ALV Comparison
Compare EXEL & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | ALV |
|---|---|---|
| Founded | 1994 | 1953 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.7B |
| IPO Year | 2000 | 1997 |
Fundamental Metrics
Financial Performance| Metric | EXEL | ALV |
|---|---|---|
| Price | $44.26 | $124.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 11 |
| Target Price | $45.45 | ★ $133.45 |
| AVG Volume (30 Days) | ★ 2.5M | 486.0K |
| Earning Date | 02-10-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 2.72% |
| EPS Growth | ★ 53.55 | 25.57 |
| EPS | 2.38 | ★ 9.69 |
| Revenue | $2,288,218,000.00 | ★ $10,614,000,000.00 |
| Revenue This Year | $9.79 | $4.71 |
| Revenue Next Year | $12.01 | $4.08 |
| P/E Ratio | $18.53 | ★ $12.91 |
| Revenue Growth | ★ 9.93 | 0.85 |
| 52 Week Low | $31.90 | $75.49 |
| 52 Week High | $49.62 | $129.54 |
Technical Indicators
Market Signals| Indicator | EXEL | ALV |
|---|---|---|
| Relative Strength Index (RSI) | 52.46 | 61.70 |
| Support Level | $43.28 | $121.59 |
| Resistance Level | $46.31 | $125.52 |
| Average True Range (ATR) | 1.44 | 1.87 |
| MACD | -0.10 | 0.42 |
| Stochastic Oscillator | 43.60 | 86.25 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ALV Autoliv Inc.
Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.